To make the samples as comparable as possible across disease stages, we studied regions within all of the biopsies where early grade neoplastic changes were found, to reduce the influence of DNA mutations in later stage disease having effects on EZH2 and to test whether the polycomb changes were occurring physically beyond the later-stage tumor itself. Here, EZH2 is linked to neoplasm.